期刊文献+

强骨宝2号对激素性大鼠骨质疏松症的影响 被引量:5

Bone Histomorphometric Study of Influence of QIANGGUBAO Ⅱ on Glucocorticoid-induced Osteoporosis in Rats
下载PDF
导出
摘要 为探讨强骨宝 2号对糖皮质激素致大鼠骨质疏松的影响 ,将 56只 3月龄雄性 SD大鼠 ,随机分为正常对照组、病理模型组、骨松宝组、强骨宝组。于第 8周和第 1 3周分 2批处死。取胫骨上 1 /3段 ,制成不脱钙骨切片标本 ,进行骨组织形态计量学测定。结果显示 :第 8周后 ,模型组与对照组相比 ,骨形成指数减少 ,骨松宝与强骨宝组的各参数与对照组相比无显著变化 ;第 1 3周后 ,模型组与对照组相比 ,衡量骨量的各项指标显著减少 ,骨松宝和强骨宝组的骨量和骨形成指标与对照组没有显著差异 ,但强骨宝的骨吸收参数值低于骨松宝组。提示强骨宝有预防泼尼松致骨质疏松的作用。 To study the influence of QIANGGUBAO Ⅱ (QGBⅡ) on glucocorticoid induced osteoporosis,56 three month old male SD rats were randomly and averagely divided into 4 groups.3 groups were modeled with prednisone (4.5mg/11g,twice each week) respectively,while group 1 (G1) taken only NS as control.And then group 2 (G2)treated with NS,group 3 (G3) GUSONGBAO,and group 4 (G4) QGBⅡ daily from the baseline.7 rats of each group were killed on 8th week and the proximal tibiae were taken for the dynamic and static histomorphometric measurement,and the same procedure was made on 13th week in another half.The results showed that the parameters of bone formation in G2 is significantly lower than that of G1 8 weeks after the experiment.In comparison with G1 13 weeks after the experiment,the parameters of bone mass and bone formation in G2 were obviously decreased,while there was no significant difference between G3 and G4.The bone resorption parameters of G4 were lower than those of G3.The results indicates that QGB Ⅱ is effective in the prevention of the glucocorticoid induced osteoporsis.
出处 《福建中医学院学报》 2001年第2期19-21,共3页 Journal of Fujian College of Traditional Chinese Medicine
基金 福建省教育厅科研基金!( JA9715 4)
关键词 骨质疏松 强骨宝2号 骨组织计量学 醋酸泼尼松 中医药疗法 osteoporosis QIANGGUBAO Ⅱ bone histomorphometric prednisone rats
  • 相关文献

参考文献8

二级参考文献26

共引文献221

同被引文献49

  • 1刘忠厚,潘子昂,王石麟.原发性骨质疏松症诊断标准的探讨[J].中国骨质疏松杂志,1997,3(1):1-15. 被引量:139
  • 2许旺.中医药治疗骨质疏松症的研究进展[J].中草药,2005,36(2):314-315. 被引量:11
  • 3刘惟莞,石明健,王红英,李宗桃,邓思清.依扑拉芬对糖皮质激素所致大鼠骨质疏松的作用[J].中国药理学通报,1995,11(6):500-503. 被引量:2
  • 4吴铁,崔燎,张志平,陈志东,李青南,廖进民,黄连芳.淫羊藿对抗肾上腺皮质激素不良反应的实验研究[J].中国中药杂志,1996,21(12):748-751. 被引量:37
  • 5Kim C H, Cheng SL, Kim GS, et al. Effect of dexamethasone on proliferation, activity, and cytokine secretion of normal human bone marrow stremal cells : possible mechanisms of glucocorticoidsinduced bone loss [J]. J Endocrinol, 1999, 162:371 -379. 被引量:1
  • 6Weinstein RS, Nicholas RW, Manolagas SC. Apoptosis of osteocyte glucocorticoid-induced osteonecrosis of the hip [ J]. Clin Endocrinol Metab, 2004, 85:2907-2912. 被引量:1
  • 7Silvestrini G, Ballanti P, Patacchioli FR, et al. Evaluation of apoptosis and the glucocorticoid receptorin the cartilage growth plate and metaphyseal bone cells of rat safterhih dose treatment with corticosterone [J]. Bone, 2000, 26 (1): 33-42. 被引量:1
  • 8Hotbauer LC, Schoppet M. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases [J]. JAMA, 2004, 292 (4) : 490 -495. 被引量:1
  • 9Brixen KT, Christensen B, Ejersted C, et al. Teriparatide (bio-ynthetic human parathyroid hormone 1 -34 ) : a new paradigm in the treatment of osteoporosis [ J]. Basic Clin Phannacol Toxicol,2004, 94 (4): 260-270. 被引量:1
  • 10Nordin BE, Need AG, Morris HA, et al. New approaches to the problems of osteoporosis [J]. Clin Orthop, 1985, 200: 181. 被引量:1

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部